About the Congress
DDDN is a comprehensive Congress fully devoted to neurotherapeutic topics. DDDN is aimed at interaction between medical specialists, neuroscientists and the industry. |
Congress Credits
The EACCME granted DDDN 2014 with 17 ECMECs
The Italian Ministry of Health granted
2,8 Italian Credits
|
Next Congress
Save the dates for the
2nd DDDN Congress:
September 3-6, 2015
Prague, Czech Republic
Secretariat
CongressMed ![]() |
Selected Debates
MANAGEMENT DILEMMAS IN MS
Debate: Life risking' therapy in MS: Where should we draw a line?
Only rarely: H.P. Hartung, Germany
More than today: I. Steiner, Israel DISEASE MODIFYING DRUGS FOR MULTIPLE SCLEROSIS: HOW SHOULD WE MONITOR TREATMENT RESPONSE?
Debate: The end points in MS disease evaluation
Should be clinical disability: A. Pachner, USA
Should be relapse rate: H.P. Hartung, Germany
Should be imaging: D.L. Arnold, Canada
Panel discussion
|
Welcome to DDDN
Dear Colleagues, we are pleased to announce the World Congress on Neuro-Therapeutics: Dilemmas, Debates & Discussions (DDDN) will be held in Basel, Switzerland, September 4-7, 2014. This ‘concept meeting’ will focus on therapeutic issues of neurological diseases.
|
|
![]() |
![]() |
Zohar Argov | Israel Steiner |